ALXN insider filings

ALEXION PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-07-23. Screen ALXN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ALXN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ALEXION PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2021-07-234Carino Tanisha — EVP & CCAODisposition to issuer (D): 59,226 @ $0EDGAR
2021-07-234Bazarko Daniel — SVP, Controller, CAODisposition to issuer (D): 60,207 @ $0 · Disposition to issuer (D): 5,300 (derivative) @ $131.25 · Disposition to issuer (D): 5,111 (derivative) @ $176.80 · Disposition to issuer (D): 3,943 (derivative) @ $180.37 · Disposition to issuer (D): 2,912 (derivative) @ $180.28EDGAR
2021-07-234SARIN ARADHANA — EVP, CFODisposition to issuer (D): 120,253 @ $0EDGAR
2021-07-234Franchini Indrani Lall — EVP, Chief Compliance OfficerDisposition to issuer (D): 116,075 @ $0 · Disposition to issuer (D): 25,165 (derivative) @ $100.14EDGAR
2021-07-234ORLOFF JOHN J — EVP, Research & DevelopmentDisposition to issuer (D): 146,511 @ $0EDGAR
2021-07-234Brennan David R — DirectorDisposition to issuer (D): 20,873 @ $0 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 · Disposition to issuer (D): 2,706 (derivative) @ $167.97 · Disposition to issuer (D): 2,294 (derivative) @ $138.86EDGAR
2021-07-234Goff Brian — EVP & Chief Commercial OfficerDisposition to issuer (D): 150,832 @ $0 · Disposition to issuer (D): 21,750 (derivative) @ $100.14EDGAR
2021-07-234HANTSON LUDWIG — CEO, DirectorDisposition to issuer (D): 580,809 @ $0 · Disposition to issuer (D): 56,762 (derivative) @ $118.83EDGAR
2021-07-234Rummelt Andreas — DirectorDisposition to issuer (D): 28,109 @ $0 · Disposition to issuer (D): 2,785 (derivative) @ $159.70 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 3,425 (derivative) @ $96.35 · Disposition to issuer (D): 3,237 (derivative) @ $85.75 · Disposition to issuer (D): 2,343 (derivative) @ $155.01EDGAR
2021-07-234Chiniara Ellen — EVP & Chief Legal OfficerDisposition to issuer (D): 116,850 @ $0EDGAR
2021-07-234Mollen John T — DirectorDisposition to issuer (D): 15,336 @ $0 · Disposition to issuer (D): 2,785 (derivative) @ $159.70 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 2,343 (derivative) @ $155.01EDGAR
2021-07-234Nader Francois — DirectorDisposition to issuer (D): 13,921 @ $0EDGAR
2021-07-234Dunsire Deborah — DirectorDisposition to issuer (D): 14,629 @ $0EDGAR
2021-07-234Reinsdorf Judith A — DirectorDisposition to issuer (D): 14,150 @ $0EDGAR
2021-07-234FRIEDMAN PAUL A — DirectorDisposition to issuer (D): 12,840 @ $0EDGAR
2021-07-234COUGHLIN CHRISTOPHER J — DirectorDisposition to issuer (D): 42,347 @ $0 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 2,706 (derivative) @ $167.97 · Disposition to issuer (D): 2,343 (derivative) @ $155.01EDGAR
2021-07-164Carino Tanisha — EVP & CCAOGrant/award (A): 25,813 @ $0EDGAR
2021-07-164Bazarko Daniel — SVP, Controller, CAOGrant/award (A): 11,060 @ $0 · Grant/award (A): 10,648 @ $0EDGAR
2021-07-164SARIN ARADHANA — EVP, CFOGrant/award (A): 26,812 @ $0 · Grant/award (A): 29,501 @ $0EDGAR
2021-07-164Franchini Indrani Lall — EVP, Chief Compliance OfficerGrant/award (A): 26,812 @ $0 · Grant/award (A): 25,813 @ $0EDGAR
2021-07-164ORLOFF JOHN J — EVP, Research & DevelopmentGrant/award (A): 30,643 @ $0 · Grant/award (A): 29,501 @ $0EDGAR
2021-07-164Goff Brian — EVP & Chief Commercial OfficerGrant/award (A): 30,643 @ $0 · Grant/award (A): 29,501 @ $0EDGAR
2021-07-164HANTSON LUDWIG — CEO, DirectorGrant/award (A): 120,894 @ $0 · Grant/award (A): 119,847 @ $0EDGAR
2021-07-164Chiniara Ellen — EVP & Chief Legal OfficerGrant/award (A): 26,812 @ $0 · Grant/award (A): 27,657 @ $0EDGAR
2021-06-094Franchini Indrani Lall — EVP, Chief Compliance OfficerTax withholding (F): 928 @ $177EDGAR
2021-06-094ORLOFF JOHN J — EVP, Research & DevelopmentTax withholding (F): 1,957 @ $177EDGAR
2021-06-094Goff Brian — EVP & Chief Commercial OfficerTax withholding (F): 1,086 @ $177EDGAR
2021-05-244Brennan David R — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 1,374 @ $0EDGAR
2021-05-244Rummelt Andreas — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 533 @ $0EDGAR
2021-05-244Mollen John T — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 673 @ $0EDGAR
2021-05-244Nader Francois — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 673 @ $0EDGAR
2021-05-244Dunsire Deborah — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 533 @ $0EDGAR
2021-05-244Reinsdorf Judith A — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 673 @ $0EDGAR
2021-05-244FRIEDMAN PAUL A — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 533 @ $0EDGAR
2021-05-244COUGHLIN CHRISTOPHER J — DirectorGrant/award (A): 1,962 @ $0 · Grant/award (A): 729 @ $0EDGAR
2021-04-014HANTSON LUDWIG — CEO, DirectorTax withholding (F): 2,332 @ $154.03EDGAR
2021-03-024Carino Tanisha — EVP & CCAOGrant/award (A): 18,033 @ $0 · Tax withholding (F): 722 @ $151.75EDGAR
2021-03-024Bazarko Daniel — SVP, Controller, CAOGrant/award (A): 7,616 @ $0EDGAR
2021-03-024SARIN ARADHANA — EVP, CFOGrant/award (A): 24,473 @ $0EDGAR
2021-03-024Franchini Indrani Lall — EVP, Chief Compliance OfficerGrant/award (A): 18,033 @ $0EDGAR
2021-03-024ORLOFF JOHN J — EVP, Research & DevelopmentGrant/award (A): 24,473 @ $0EDGAR
2021-03-024Goff Brian — EVP & Chief Commercial OfficerGrant/award (A): 24,473 @ $0EDGAR
2021-03-024HANTSON LUDWIG — CEO, DirectorGrant/award (A): 83,725 @ $0EDGAR
2021-03-024Chiniara Ellen — EVP & Chief Legal OfficerGrant/award (A): 19,321 @ $0EDGAR
2020-12-214Bazarko Daniel — SVP, Controller, CAOOption exercise (M): 13,066 @ $97.58 · Option exercise (M): 11,000 @ $140.16 · Sale (S): 9,900 @ $157.59 · Sale (S): 13,066 @ $157.76 · Sale (S): 1,100 @ $158 · Option exercise (M): 13,066 (derivative) @ $0 · +1 moreEDGAR
2020-12-184Franchini Indrani Lall — EVP, Chief Compliance OfficerGrant/award (A): 37,965 @ $0 · Tax withholding (F): 16,925 @ $157.96 · Tax withholding (F): 2,913 @ $157.96EDGAR
2020-12-184ORLOFF JOHN J — EVP, Research & DevelopmentGrant/award (A): 40,677 @ $0 · Tax withholding (F): 18,134 @ $157.96 · Tax withholding (F): 3,261 @ $157.96 · Grant/award (A): 40 @ $93.53EDGAR
2020-12-184Goff Brian — EVP & Chief Commercial OfficerGrant/award (A): 40,677 @ $0 · Tax withholding (F): 18,134 @ $157.96 · Tax withholding (F): 3,261 @ $157.96EDGAR
2020-12-184HANTSON LUDWIG — CEO, DirectorGrant/award (A): 162,707 @ $0 · Tax withholding (F): 72,533 @ $157.96 · Tax withholding (F): 13,059 @ $157.96EDGAR
2020-12-184Chiniara Ellen — EVP & Chief Legal OfficerGrant/award (A): 37,965 @ $0 · Tax withholding (F): 16,925 @ $157.96 · Tax withholding (F): 2,988 @ $157.96 · Grant/award (A): 56 @ $95.53EDGAR

Recent 8-K events — ALEXION PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-07-228-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-07-208-K2.02 — Results of Operations and Financial ConditionEDGAR
2021-05-138-K/A5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-05-118-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-05-048-K8.01 — Other EventsEDGAR
2021-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-03-158-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2021-02-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-01-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ALXN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs